Single domain antibodies that neutralize sars-cov-2
Номер патента: EP4294834A2
Опубликовано: 27-12-2023
Автор(ы): Jianliang XU, Rafael Cristian CASELLAS
Принадлежит: US Department of Health and Human Services
Опубликовано: 27-12-2023
Автор(ы): Jianliang XU, Rafael Cristian CASELLAS
Принадлежит: US Department of Health and Human Services
Реферат: Single-domain antibodies against SARS-CoV-2 are provided. The single-domain antibodies have been shown to have neutralizing activity against SARS-CoV-2 and can be used as a diagnostic and/or therapeutic in patients with coronavirus infection, such as COVID-19; and in diseases and disorders related to, or resulting from, coronavirus infection.
Single domain antibodies that neutralize sars-cov-2
Номер патента: AU2022224636A1. Автор: Rafael Cristian CASELLAS,Jianliang XU. Владелец: US Government. Дата публикации: 2023-09-07.